Overview As a part of our commitment to discover, develop, and deliver medicines to the patients who depend on us, we believe in supporting investigator-initiated research (IIR) to advance medical and scientific knowledge in our research areas of interest. We define IIR as unsolicited research conceived, initiated, and conducted independently of Ionis. An external investigator […]
At Ionis, our efforts begin and end with the patient in mind. From discovery to development to getting medicines into the hands of those who need it, we are inspired by the needs of the patient communities we serve, and fueled by the promise of our science. Every aspect of what we do is grounded […]
Fred and Lynne have been married for 40+ years. When talking about Fred’s illness, Lynne often looks back to when she said, “I do,” and thinks about how she had no idea at the time what “in sickness and in health” would really mean.
Dr. Monia is the chief executive officer, a member of the board of directors and a founding scientist of Ionis Pharmaceuticals. His contributions at Ionis include research into the medicinal chemistry and mechanisms of action of RNA-targeting modalities to treat human diseases, most notably antisense-based therapeutic strategies. Dr. Monia has extensive experience across a range […]